Hôpital Européen Georges-Pompidou (HEGP)

Paris 75908

0 studies enrolling now · 5 studies all time

What they study most

Advanced Renal Cell Carcinoma, Cardiovascular Diseases, Colorectal Cancer, Esophageal Squamous Cell Carcinoma, Gastric Cancer, Head and Neck Squamous Cell Carcinoma, Hypertension, Metastatic Renal Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Ovarian Cancer, Pulmonary Embolism, Vascular Diseases

Studies at this site

• Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism — Running, not enrolling
• Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination — Running, not enrolling
• Trial on Radical Upfront Surgery in Advanced Ovarian Cancer — Running, not enrolling
• The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension — Running, not enrolling
• CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma — Completed